PNC-27 vs Thymosin Alpha-1

PNC-27

Molecular formula

C₁₈₈H₂₉₃N₅₃O₄₄S

Molecular weight

4031.73 g/mol

Half-life

2-4 hours (estimated from preclinical data)

Bioavailability

High when injected subcutaneously

CAS number

1159861-00-3

Thymosin Alpha-1

Molecular formula

C₁₂₉H₂₁₅N₃₃O₅₅

Molecular weight

3108.32 g/mol

Half-life

Approximately 2 hours

Bioavailability

High when injected subcutaneously (rapid absorption, peak at ~2 hours)

CAS number

62304-98-7

PNC-27

No dose levels recorded.

Thymosin Alpha-1

PNC-27

Solid Tumor Research

PNC-27 has shown remarkable results against solid tumors in lab studies. It's been tested against breast, pancreatic, colon, and ovarian cancer cells—and in each case, it killed the cancer cells while the healthy cells next to them stayed perfectly fine. That's the holy grail of cancer research.

Leukemia and Blood Cancer Studies

In studies on acute myeloid leukemia (AML), PNC-27 wiped out cancer cells within just 4 hours. It works on several types of leukemia cells (U937, OCI-AML3, HL-60) by targeting a protein that only shows up on cancer cell surfaces. Normal blood cells? Completely unharmed.

Cancer Stem Cell Targeting

Here's where PNC-27 gets really interesting: it can kill cancer stem cells. These are the sneaky cells that often survive chemo and cause cancer to come back. PNC-27 has shown it can destroy CD44+ colon cancer stem cells, which is a big deal for preventing recurrence.

Drug-Resistant Cancer Research

When cancers stop responding to regular chemotherapy, researchers need new approaches. PNC-27 works through a completely different mechanism than traditional chemo drugs, so it may be effective against cancers that have become resistant to other treatments.

Thymosin Alpha-1

Chronic Hepatitis B or C Support

Thymosin Alpha-1 has its strongest clinical evidence here. Multiple trials show it helps clear viral loads and normalize liver enzymes, especially when combined with antiviral medications. It's approved in over 30 countries specifically for hepatitis treatment.

Cancer Treatment Support

When used alongside chemotherapy, Thymosin Alpha-1 may help maintain immune function that chemo tends to suppress. Research in lung cancer, melanoma, and liver cancer shows improved outcomes when added to standard treatments. It helps your immune system keep fighting even during tough treatments.

Age-Related Immune Decline

As you age, your thymus shrinks and produces less thymosin naturally—a process called immunosenescence. Supplementing with Thymosin Alpha-1 may help compensate, keeping your immune defenses more youthful and responsive. Think of it as replacing what your body makes less of over time.

Severe Infection Recovery

In sepsis and critical infections, Thymosin Alpha-1 has shown promise for reducing mortality by helping restore immune balance. It's particularly interesting because it modulates immunity rather than just boosting it—calming overreaction while enhancing pathogen-fighting ability.

PNC-27

Thymosin Alpha-1

PNC-27

Evidence level

Strong preclinical (extensive animal studies)

FDA status

Research compound

Safety overview

Here's the really cool thing about PNC-27: in all the lab and animal studies so far, it ONLY attacks cancer cells. Normal, healthy cells are completely ignored because they don't have the protein (HDM-2) on their surface that PNC-27 targets. Animal studies using doses up to 40 mg/kg showed tumors shrinking or disappearing with zero damage to normal tissues. That said, it hasn't been tested in human clinical trials yet, so we're still learning.

Thymosin Alpha-1

Evidence level

Moderate human trials (Phase 1-2)

FDA status

Not FDA approved. There is no thymalfasin application in Drugs@FDA. It is used outside the US (as Zadaxin) for chronic hepatitis B and as an immune adjuvant.

Safety overview

Thymosin Alpha-1 has one of the most extensive safety records of any peptide, with decades of clinical use across multiple countries. Studies consistently report minimal side effects—mostly limited to mild injection site reactions. The 2-hour half-life means it doesn't accumulate in your system. It's been used safely in thousands of patients with hepatitis, cancer, and other serious conditions.

PNC-27

Choose PNC-27 if…

• Cancer research protocols
• Oncology support research
• Targeting treatment-resistant cancers
• Cancer stem cell research

Thymosin Alpha-1

Choose Thymosin Alpha-1 if…

• Immune system strengthening
• Chronic infection support
• Cancer adjunct therapy
• Healthy aging immune support